Sign in
4

Changes in Ownership

Insight Molecular Diagnostics Inc. Filed Acc 0001493152-23-006302

Options or other derivatives

  • CEO acquired 116,426 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Riggs Josh CEO 2023-02-24 Grant or award · Option to Purchase Common Stock +116,426 116,426 D
Loading xslF345X03/ownership.xml…